General Information of Drug (ID: DM7X99Z)

Drug Name
NM504
Indication
Disease Entry ICD 11 Status REF
Diabetic complication 5A2Y Phase 1 [1]
Type-2 diabetes 5A11 Phase 0 [2]
Cross-matching ID
TTD ID
D02CUN
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT01866462) Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin. U.S. National Institutes of Health.